최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
DataON 바로가기다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
Edison 바로가기다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
Kafe 바로가기국가/구분 | United States(US) Patent 등록 |
---|---|
국제특허분류(IPC7판) |
|
출원번호 | US-0780723 (2010-05-14) |
등록번호 | US-8825127 (2014-09-02) |
발명자 / 주소 |
|
출원인 / 주소 |
|
대리인 / 주소 |
|
인용정보 | 피인용 횟수 : 1 인용 특허 : 510 |
The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
1. A method for analyzing data from a continuous glucose sensor, comprising: receiving sensor data from a first transcutaneous continuous glucose sensor;receiving reference data from a second transcutaneous continuous glucose sensor;calculating, using a processor, a conversion function based on the
1. A method for analyzing data from a continuous glucose sensor, comprising: receiving sensor data from a first transcutaneous continuous glucose sensor;receiving reference data from a second transcutaneous continuous glucose sensor;calculating, using a processor, a conversion function based on the reference data and prior information obtained from at least one of in vitro testing of at least one continuous glucose sensor or in vivo use of at least one continuous glucose sensor;validating, using the processor, the conversion function based on additional prior information obtained from at least one of in vitro testing of at least one continuous glucose sensor or in vivo use of at least one continuous glucose sensor; andconverting, using the processor, the sensor data to calibrated data using the validated conversion function. 2. The method of claim 1, further comprising: transcutaneously inserting at least a portion of the first continuous glucose sensor, wherein the prior information is obtained prior to inserting. 3. The method of claim 1, further comprising outputting information to an external device. 4. The method of claim 3, wherein the external device comprises an insulin delivery device. 5. The method of claim 3, wherein the external device comprises at least one of a server, a personal computer, a personal digital assistant, an insulin pump, and an insulin pen, a medical device, a pacemaker, a telemetry device, or an infusion device. 6. The method of claim 1, wherein the processor module is integral with at least one of a personal computer, a personal digital assistant, a cell phone, a non-continuous glucose sensor or an insulin delivery device. 7. The method of claim 1, wherein the calculating is performed without non-continuous glucose measurements. 8. A system for analyzing data from a continuous glucose sensor, comprising: a sensor data receiving module configured to receive sensor data from a first transcutaneous continuous glucose sensor;a reference data receiving module configured to receive reference data from a second transcutaneous continuous glucose sensor; anda processor module configured to calculate a conversion function based on the reference data and prior information obtained from at least one of in vitro testing of at least one continuous glucose sensor or in vivo use of at least one continuous glucose sensor, validate the conversion function based on additional prior information obtained from at least one of in vitro testing of at least one continuous glucose sensor or in vivo use of at least one continuous glucose sensor, and convert the sensor data to calibrated data using the validated conversion function. 9. The system of claim 8, further comprising: an introducer; andthe first continuous glucose sensor coupled to the introducer for inserting at least a portion of the analyte sensor transcutaneously, wherein the prior information is obtained prior to inserting in a host by the introducer. 10. The system of claim 8, wherein the analyte sensor is calibrated without non-continuous analyte measurements. 11. The system of claim 8, wherein the system further comprises an external device, and wherein the processor module is configured to output information to the external device. 12. The system of claim 11, wherein the external device comprises an insulin delivery device. 13. The system of claim 11, wherein the external device comprises at least one of a server, a personal computer, a personal digital assistant, an insulin pump, and an insulin pen, a medical device, a pacemaker, a telemetry device or an infusion device. 14. The system of claim 8, wherein the processor module is integral with at least one of a personal computer, a personal digital assistant, a cell phone, a non-continuous glucose sensor, or an insulin delivery device.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.